A detailed history of Keystone Wealth Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keystone Wealth Services, LLC holds 6,201 shares of BMY stock, worth $357,487. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,201
Previous 6,506 4.69%
Holding current value
$357,487
Previous $270,000 18.52%
% of portfolio
0.1%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$39.66 - $51.75 $12,096 - $15,783
-305 Reduced 4.69%
6,201 $320,000
Q2 2024

Jul 12, 2024

BUY
$40.25 - $52.99 $281 - $370
7 Added 0.11%
6,506 $270,000
Q1 2024

Apr 12, 2024

SELL
$47.98 - $54.4 $19,863 - $22,521
-414 Reduced 5.99%
6,499 $352,000
Q4 2023

Jan 17, 2024

SELL
$48.48 - $57.85 $9,938 - $11,859
-205 Reduced 2.88%
6,913 $354,000
Q3 2023

Oct 05, 2023

SELL
$57.89 - $64.73 $14,704 - $16,441
-254 Reduced 3.45%
7,118 $413,000
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $6,116 - $6,791
-96 Reduced 1.29%
7,372 $471,000
Q1 2023

Apr 07, 2023

BUY
$65.71 - $74.53 $9,725 - $11,030
148 Added 2.02%
7,468 $517,000
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $616 - $729
9 Added 0.12%
7,320 $526,000
Q3 2022

Oct 31, 2022

BUY
$0.13 - $76.84 $1 - $691
9 Added 0.12%
7,311 $520,000
Q2 2022

Jul 13, 2022

SELL
$72.62 - $79.98 $3,050 - $3,359
-42 Reduced 0.57%
7,302 $562,000
Q1 2022

Apr 21, 2022

BUY
$61.48 - $73.72 $21,948 - $26,318
357 Added 5.11%
7,344 $536,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $374,712 - $436,827
6,987 New
6,987 $436,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Keystone Wealth Services, LLC Portfolio

Follow Keystone Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Wealth Services, LLC with notifications on news.